Oncology seminars
October 2026
Mitochondrial Apoptotic Priming – The Key to Cancer Response
Anthony Letai· National Cancer Institute
Mon, Oct 5 · 20:30 UTC · Washington, and Zoom · Hybrid
Anthony Letai discusses how understanding programmed cell death can guide the selection of cancer treatments. The seminar explains how apoptotic signalling can be measured and how these measurements can identify drugs capable of killing cancer cells. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Monday 5 October 2026, 16:30–17:30 EDT (America/New_York; UTC−4). Use the attendance registration form or the event’s Zoom link on the organizer page. Organized by Georgetown’s Distinguished Scientist Seminar Series. Letai is Director of the National Cancer Institute. An in-person reception follows the seminar.
March 2023
Aging promotes reactivation from metastatic melanoma dormancy
Mitchell Fane· Fox Chase Cancer Center
Recorded
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
Nataliya Prokhnevska· MSKCC
Recorded
February 2023
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells
Adrià Cañellas-Socias· BIST
Recorded
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis
Patricia Altea Manzano· VIB-KU Leuven Center for Cancer Biology
Recorded
End of results.